Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hemangioma 6 Hemangioma, Capillary 4 Multiple Myeloma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Tuberous Sclerosis 1 Prostatic Neoplasms 1 Neuroblastoma 1 Melanoma 1 Hemangiosarcoma 1 Hemangioma, Cavernous, Central Nervous System 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Docetaxel 158 Prednisone 131 Leuprolide 95 bicalutamide 86 enzalutamide 83 Radiotherapy 80 Goserelin 80 Abiraterone Acetate 76 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54 Magnetic Resonance Spectroscopy 46 Zoledronic Acid 44 gallium 68 PSMA-11 37 Flutamide 34 abiraterone 32 Estramustine 32 radium Ra 223 dichloride 30 apalutamide 27 Surveys and Questionnaires 26 Gonadotropin-Releasing Hormone 26 Androgen Antagonists 25 cabazitaxel 24 Radiosurgery 24 Dutasteride 22 sipuleucel-T 21 Prednisolone 21 Triptorelin Pamoate 20 Paclitaxel 20 luprolide acetate gel depot 19 Radiation 19 Exercise 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Propranolol × Clear all

NCT05679193 2024-05-29

PeP-RALP

Oslo University Hospital

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡